163 related articles for article (PubMed ID: 25129201)
1. Prevalence and factors associated with polypharmacy in Victorian adults with intellectual disability.
Haider SI; Ansari Z; Vaughan L; Matters H; Emerson E
Res Dev Disabil; 2014 Nov; 35(11):3071-80. PubMed ID: 25129201
[TBL] [Abstract][Full Text] [Related]
2. Health and wellbeing of Victorian adults with intellectual disability compared to the general Victorian population.
Haider SI; Ansari Z; Vaughan L; Matters H; Emerson E
Res Dev Disabil; 2013 Nov; 34(11):4034-42. PubMed ID: 24036484
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease in older people with intellectual disability: results of the HA-ID study.
de Winter CF; Echteld MA; Evenhuis HM
Res Dev Disabil; 2014 Mar; 35(3):726-32. PubMed ID: 24287320
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study.
Chitty KM; Evans E; Torr JJ; Iacono T; Brodaty H; Sachdev P; Trollor JN
Aust N Z J Psychiatry; 2016 Apr; 50(4):352-62. PubMed ID: 26019276
[TBL] [Abstract][Full Text] [Related]
6. Prescription errors in older individuals with an intellectual disability: prevalence and risk factors in the Healthy Ageing and Intellectual Disability Study.
Zaal RJ; van der Kaaij AD; Evenhuis HM; van den Bemt PM
Res Dev Disabil; 2013 May; 34(5):1656-62. PubMed ID: 23501585
[TBL] [Abstract][Full Text] [Related]
7. Medication and supplement use in older people with and without intellectual disability: An observational, cross-sectional study.
Peklar J; Kos M; O'Dwyer M; McCarron M; McCallion P; Kenny RA; Henman MC
PLoS One; 2017; 12(9):e0184390. PubMed ID: 28877256
[TBL] [Abstract][Full Text] [Related]
8. Medication review using a Systematic Tool to Reduce Inappropriate Prescribing (STRIP) in adults with an intellectual disability: A pilot study.
Zaal RJ; Ebbers S; Borms M; Koning Bd; Mombarg E; Ooms P; Vollaard H; van den Bemt PM; Evenhuis HM
Res Dev Disabil; 2016 Aug; 55():132-42. PubMed ID: 27065309
[TBL] [Abstract][Full Text] [Related]
9. Obesity and associated factors in adults with intellectual disability.
Hsieh K; Rimmer JH; Heller T
J Intellect Disabil Res; 2014 Sep; 58(9):851-63. PubMed ID: 24256455
[TBL] [Abstract][Full Text] [Related]
10. Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.
O'Connell J; Henman MC; McMahon N; Burke É; McCallion P; McCarron M; O'Dwyer M
Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):482-492. PubMed ID: 32134549
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study.
O'Dwyer M; Peklar J; McCallion P; McCarron M; Henman MC
BMJ Open; 2016 Apr; 6(4):e010505. PubMed ID: 27044582
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of cardio-metabolic risk factors among adolescents with intellectual disability.
Wallén EF; Müllersdorf M; Christensson K; Malm G; Ekblom O; Marcus C
Acta Paediatr; 2009 May; 98(5):853-9. PubMed ID: 19183118
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacy and psychotropic polypharmacy in adults with intellectual disability: a cross-sectional total population study.
McMahon M; Hatton C; Bowring DL
J Intellect Disabil Res; 2020 Nov; 64(11):834-851. PubMed ID: 32902029
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia and metabolic syndrome) in older people with intellectual disability: results of the HA-ID study.
de Winter CF; Bastiaanse LP; Hilgenkamp TI; Evenhuis HM; Echteld MA
Res Dev Disabil; 2012; 33(6):1722-31. PubMed ID: 22699246
[TBL] [Abstract][Full Text] [Related]
16. Overweight and obesity in older people with intellectual disability.
de Winter CF; Bastiaanse LP; Hilgenkamp TI; Evenhuis HM; Echteld MA
Res Dev Disabil; 2012; 33(2):398-405. PubMed ID: 22119687
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of malnutrition in institutionalized intellectually disabled patients].
Bronberg RA; Alfaro EL; Bejarano IF; Dipierri JE
Medicina (B Aires); 2011; 71(1):1-8. PubMed ID: 21296713
[TBL] [Abstract][Full Text] [Related]
18. Social determinants and psychological distress among Aboriginal and Torres Strait islander adults in the Australian state of Victoria: a cross-sectional population based study.
Markwick A; Ansari Z; Sullivan M; McNeil J
Soc Sci Med; 2015 Mar; 128():178-87. PubMed ID: 25618607
[TBL] [Abstract][Full Text] [Related]
19. Unnoticed post-void residual urine volume in people with moderate to severe intellectual disabilities: prevalence and risk factors.
de Waal KH; Tinselboer BM; Evenhuis HM; Penning C
J Intellect Disabil Res; 2009 Sep; 53(9):772-9. PubMed ID: 19627424
[TBL] [Abstract][Full Text] [Related]
20. Multimorbidity in older adults with intellectual disabilities.
Hermans H; Evenhuis HM
Res Dev Disabil; 2014 Apr; 35(4):776-83. PubMed ID: 24529858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
